Fig. 7

LINC02154 immune microenvironment associated analysis and drug sensitivity analysis. A Relationship between LINC02154 expression type and immune molecular typing. B Analysis of immune function in high LINC02154 and low LINC02154 expression groups. C Correlation analysis between LINC02154 and positive markers related to immunotherapy. D Analysis of the correlation between LINC02154 and critical steps of the cancer immunity cycle. E Immune checkpoint analysis of high LINC02154 and low LINC02154 expression groups. F-L Susceptibility analysis was performed separately for axitinib, doxorubicin, gemcitabine, pazopanib, sorafenib, sunitinib, and temsirolimus in high LINC02154 expression group and low LINC02154 expression group